Literature DB >> 18303003

Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women.

Patricia G Moorman1, Brian Calingaert, Rachel T Palmieri, Edwin S Iversen, Rex C Bentley, Susan Halabi, Andrew Berchuck, Joellen M Schildkraut.   

Abstract

Ovarian cancer is most frequently diagnosed in postmenopausal women; however, the strongest risk predictors, pregnancy and oral contraceptive use, occur in most women in their twenties and thirties. Relatively few studies have examined how reproductive risk factors vary between pre- and postmenopausal ovarian cancer. The authors used data from a population-based, case-control study of ovarian cancer (896 cases, 967 controls) conducted in North Carolina from 1999 to 2006. Odds ratios and 95% confidence intervals were calculated by using unconditional logistic regression. Inverse associations with ovarian cancer were observed with duration of oral contraceptive use, later age at last use, and more recent use among premenopausal women; no significant associations were found for postmenopausal women. Analyses limited to oral contraceptive users showed that duration was a more significant predictor of risk than was timing of use. Parity was inversely associated with premenopausal but not postmenopausal ovarian cancer. Later age at pregnancy was associated with reduced risk for both pre- and postmenopausal women. Analyses among parous women showed that pregnancy timing was a stronger risk predictor than number of pregnancies. Findings suggest that associations between ovarian cancer and reproductive characteristics vary by menopausal status. Additional research is needed to further elucidate risk factors for postmenopausal disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303003      PMCID: PMC2663520          DOI: 10.1093/aje/kwn006

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  25 in total

1.  Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States).

Authors:  Patricia G Moorman; Joellen M Schildkraut; Brian Calingaert; Susan Halabi; Marilyn F Vine; Andrew Berchuck
Journal:  Cancer Causes Control       Date:  2002-11       Impact factor: 2.506

2.  Beyond ovulation: oral contraceptives and epithelial ovarian cancer.

Authors:  V Siskind; A Green; C Bain; D Purdie
Journal:  Epidemiology       Date:  2000-03       Impact factor: 4.822

3.  Timing of pregnancy and the risk of epithelial ovarian cancer.

Authors:  David C Whiteman; Victor Siskind; David M Purdie; Adèle C Green
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-01       Impact factor: 4.254

4.  Incessant ovulation--a factor in ovarian neoplasia?

Authors:  M F Fathalla
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

5.  Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines.

Authors:  S Z Bu; D L Yin; X H Ren; L Z Jiang; Z J Wu; Q R Gao; G Pei
Journal:  Cancer       Date:  1997-05-15       Impact factor: 6.860

6.  Steroid hormonal regulation of proliferative, p53 tumor suppressor, and apoptotic responses of sheep ovarian surface epithelial cells.

Authors:  William J Murdoch; Edward A Van Kirk
Journal:  Mol Cell Endocrinol       Date:  2002-01-15       Impact factor: 4.102

7.  Time since last birth and the risk of ovarian cancer.

Authors:  F Chiaffarino; F Parazzini; E Negri; G Benzi; G Scarfone; S Franceschi; C La Vecchia
Journal:  Gynecol Oncol       Date:  2001-05       Impact factor: 5.482

Review 8.  Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.

Authors:  Tomas Riman; Staffan Nilsson; Ingemar R Persson
Journal:  Acta Obstet Gynecol Scand       Date:  2004-09       Impact factor: 3.636

9.  Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status?

Authors:  Hannah Kuper; Daniel W Cramer; Linda Titus-Ernstoff
Journal:  Cancer Causes Control       Date:  2002-06       Impact factor: 2.506

10.  Obesity, weight gain, and ovarian cancer.

Authors:  Kathleen M Fairfield; Walter C Willett; Bernard A Rosner; JoAnn E Manson; Frank E Speizer; Susan E Hankinson
Journal:  Obstet Gynecol       Date:  2002-08       Impact factor: 7.661

View more
  52 in total

1.  Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies.

Authors:  Nan-Nan Luan; Qi-Jun Wu; Ting-Ting Gong; Emily Vogtmann; Yong-Lai Wang; Bei Lin
Journal:  Am J Clin Nutr       Date:  2013-08-21       Impact factor: 7.045

2.  Unbalanced estrogen metabolism in ovarian cancer.

Authors:  Muhammad Zahid; Cheryl L Beseler; James B Hall; Tricia LeVan; Ercole L Cavalieri; Eleanor G Rogan
Journal:  Int J Cancer       Date:  2014-01-25       Impact factor: 7.396

3.  Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.

Authors:  Merlise A Clyde; Rachel Palmieri Weber; Edwin S Iversen; Elizabeth M Poole; Jennifer A Doherty; Marc T Goodman; Roberta B Ness; Harvey A Risch; Mary Anne Rossing; Kathryn L Terry; Nicolas Wentzensen; Alice S Whittemore; Hoda Anton-Culver; Elisa V Bandera; Andrew Berchuck; Michael E Carney; Daniel W Cramer; Julie M Cunningham; Kara L Cushing-Haugen; Robert P Edwards; Brooke L Fridley; Ellen L Goode; Galina Lurie; Valerie McGuire; Francesmary Modugno; Kirsten B Moysich; Sara H Olson; Celeste Leigh Pearce; Malcolm C Pike; Joseph H Rothstein; Thomas A Sellers; Weiva Sieh; Daniel Stram; Pamela J Thompson; Robert A Vierkant; Kristine G Wicklund; Anna H Wu; Argyrios Ziogas; Shelley S Tworoger; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2016-10-03       Impact factor: 4.897

4.  Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Joanne Kotsopoulos; Jan Lubinski; Jacek Gronwald; Cezary Cybulski; Rochelle Demsky; Susan L Neuhausen; Charmaine Kim-Sing; Nadine Tung; Susan Friedman; Leigha Senter; Jeffrey Weitzel; Beth Karlan; Pal Moller; Ping Sun; Steven A Narod
Journal:  Int J Cancer       Date:  2014-12-18       Impact factor: 7.396

5.  Reproductive factors and ovarian cancer risk in African-American women.

Authors:  Patricia G Moorman; Anthony J Alberg; Elisa V Bandera; Jill Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Edward S Peters; Ann G Schwartz; Paul Terry; Sydnee Crankshaw; Frances Wang; Joellen M Schildkraut
Journal:  Ann Epidemiol       Date:  2016-07-18       Impact factor: 3.797

Review 6.  Current understanding of risk factors for ovarian cancer.

Authors:  Thanasak Sueblinvong; Michael E Carney
Journal:  Curr Treat Options Oncol       Date:  2009-07-15

7.  Ovarian cancer risk factors in African-American and white women.

Authors:  Patricia G Moorman; Rachel T Palmieri; Lucy Akushevich; Andrew Berchuck; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2009-07-15       Impact factor: 4.897

8.  Parity and Oral Contraceptive Use in Relation to Ovarian Cancer Risk in Older Women.

Authors:  Valerie McGuire; Patricia Hartge; Linda M Liao; Rashmi Sinha; Leslie Bernstein; Alison J Canchola; Garnet L Anderson; Marcia L Stefanick; Alice S Whittemore
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-04-12       Impact factor: 4.254

9.  The utility of web mining for epidemiological research: studying the association between parity and cancer risk.

Authors:  Georgia Tourassi; Hong-Jun Yoon; Songhua Xu; Xuesong Han
Journal:  J Am Med Inform Assoc       Date:  2015-11-27       Impact factor: 4.497

10.  Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer.

Authors:  Joellen M Schildkraut; Edwin S Iversen; Melanie A Wilson; Merlise A Clyde; Patricia G Moorman; Rachel T Palmieri; Regina Whitaker; Rex C Bentley; Jeffrey R Marks; Andrew Berchuck
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.